Hikma Advances $250m Buyback, Tightening Share Count

Hikma Pharmaceuticals ( (GB:HIK) ) has shared an update.

Hikma Pharmaceuticals has continued executing its $250 million share repurchase programme, buying back 388,189 ordinary shares between 5 and 8 May 2026 on the London Stock Exchange and CBOE Europe at prices around 1,402.5 to 1,445 pence per share. The company plans to cancel these shares, which will reduce the number of shares in issue and is likely to enhance earnings per share and capital returns for investors.

Since launching the buyback in late February, Hikma has acquired 5,735,311 shares for a total cost of £73.7 million, while also retaining 12,833,233 shares in treasury. Following settlement and cancellation of the latest tranche, Hikma will have 216,151,142 ordinary shares in issue, a lower share count that tightens the free float and underscores management’s confidence in the company’s valuation and cash generation.

The most recent analyst rating on (GB:HIK) stock is a Buy with a £1870.00 price target. To see the full list of analyst forecasts on Hikma Pharmaceuticals stock, see the GB:HIK Stock Forecast page.

Spark’s Take on HIK Stock

According to Spark, TipRanks’ AI Analyst, HIK is a Neutral.

The score is held back primarily by weakening cash generation and a notably bearish technical trend (oversold and trading below key moving averages). These are partially offset by attractive valuation (low P/E and strong dividend yield) and a constructive earnings-call outlook supported by guidance comfort and a GBP 250m buyback, despite near-term injectable headwinds.

To see Spark’s full report on HIK stock, click here.

More about Hikma Pharmaceuticals

Hikma Pharmaceuticals is a multinational generic and specialty pharmaceuticals manufacturer listed in London and on Nasdaq Dubai. The company focuses on supplying injectable medicines, branded and non-branded generics, and other critical treatments to markets in the Middle East, North Africa, Europe and the U.S., with an emphasis on hospital and specialty care segments.

Average Trading Volume: 1,371,829

Technical Sentiment Signal: Hold

Current Market Cap: £3.04B

Learn more about HIK stock on TipRanks’ Stock Analysis page.